Neonatal hyperinsulinism: clinicopathologic correlation

作者:Delonlay P; Simon A; Rolland L Galmiche; Giurgea I; Verkarre V; Aigrain Y; Santiago Ribeiro M J; Polak M; Robert J J; Bellanne Chantelot C; Brunelle F; Nihoul Fekete C; Jaubert F*
来源:Human Pathology, 2007, 38(3): 387-399.
DOI:10.1016/j.humpath.2006.12.007

摘要

Neonatal hyperinsulinism is a life-threatening disease that, when treated by total pancreatectomy, leads to diabetes and pancreatic insufficiency. A more conservative approach is now possible since the separation of the disease into a nonrecurring focal form, which is cured by partial surgery, and a diffuse form, which necessitates total pancreas removal only in cases of medical treatment failure. The pathogenesis of the disease is now divided into K-channel disease (hyperinsulinemic hypoglycemia, familial [HHF] 1 and 2), which can mandate surgery, and other metabolic causes, HHF 3 to 6, which are treated medically in most patients. The diffuse form is inherited as a recessive gene on chromosome 11, whereas most cases of the focal form are caused by a sulfonylurea receptor I defect inherited from the father, which is associated with a loss of heterozygosity on the corresponding part of the mother's chromosome 11. The rare bifocal forms result from a maternal loss of heterozygosity specific to each focus. Paternal disomy of chromosome 11 is a rare cause of a condition similar to Beckwith-Wiedemann syndrome. A preoperative PET scan with fluorodihydroxyphenylalanine and perioperative frozen-section confirmation are the types of studies done before surgery when needed. Adult variants of the disease are less well defined at the present time.

  • 出版日期2007-3
  • 单位中国地震局